Demographic considerations in tacrolimus pharmacokinetics

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1359-1364

  Fitzsimmons, W E ^a   Bekersky, I ^a   Dressler, D ^a   Raye, K ^a   Hodosh, E ^a   Mekki, Q ^a  

^a Fujisawa USA ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RACE;

EID: 0031860765     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00275-9     Document Type: Conference Paper

References (13)

1. Lindholm A, Welsh M, Alton C, et al: Clin Pharmacol Ther 52:359, 1992
2. Lindholm A, Kahan BD: Clin Pharmacol Ther 54:205, 1993
3. Kato R: Drug Metab Rev 3:1, 1974
4. Kato R, Kamataki T: Xenobiotica 12:787, 1982
5. Food and Drug Administration: Fed Regist 58:39406, 1993
6. Wilson K: Clin Pharmacokinet 9:189, 1984
7. Hunt CM, Westerkam WR, Stave GM: Biochem Pharmacol 44:275, 1992
8. Johnson JA, Akers WS, LeDay AM, et al: Clin Pharmacol Ther 61:154, 1997
9. Slattum PW, Ramchandani VA, Venitz J: Clin Pharmacol Ther 61:183, 1997
10. Hulst LK, Fleishaker JC, Peters GR, et al: Clin Pharmacol Ther 55:378, 1997
11. Kaiko RF, Benziger DP, Fitzmartin RD, et al: Clin Pharmacol Ther 59:52, 1996
12. Kahan BD, Kramer WG, Wideman C, et al: Transplantation 41:459, 1986
13. Peters DH, Fitton A, Plosker GL, et al: Drugs 46:746, 1993